Use of real‐time near‐infrared fluorescence to assess gastric viability in dogs with gastric dilatation volvulus: A case‐control study
Veterinary Surgery · 2024
DOI: 10.1111/vsu.14067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Surgery, 2024. Verfasst von Kaitlyn M Mullen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Dog Diseases, Stomach Volvulus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: American College of Veterinary Surgeons Foundation, Doberman Pinscher Club of America, Great Dane Club of America.
Abstract (Originalsprache)
Objective
To describe near‐infrared fluorescence (NIRF) for assessment of gastric viability and describe NIRF's influence on the surgeon's operative strategy in dogs with gastric dilatation and volvulus (GDV). Study design Prospective clinical trial. Animals Twenty dogs with GDV and 20 systemically healthy dogs.
Methods
Following gastric derotation, the surgeon's subjective assessment of gastric viability was recorded prior to near‐infrared imaging. Changes in the surgeon's initial assessment of viability based on the visual pattern of gastric fluorescence was recorded. If nonviable (lack of defined vessels), a partial gastrectomy was performed and submitted for histopathology. The stapled gastrectomy line was imaged. Viable (defined vessels) and nonviable fluorescence intensities were compared with healthy dogs undergoing surgery for nongastrointestinal disease.
Results
Subjective assessment diagnosed 17 viable and three nonviable GDVs (2 fundi; 1 cardia). Near‐infrared imaging demonstrated nonviable gastric fluorescence in 4 dogs (3 fundi/cardia; 1 fundus). The surgeon's margins for resection were altered in 3/20 dogs. Fluorescence intensity (cardia, fundus, body, pylorus) was lower in GDV viable (30.59%, p = .04; 38.17%, p < .01; 51.18%, p < .01; 44.12%, p = .01) and nonviable (11.00%, p < .01; 4.33%, p < .01; 57.67%, p = .22; 54.33%, p = .72) dogs compared to healthy controls (44.7%, 70.05%, 84.00%, 63.95%). Fundic fluorescence was less in nonviable gastric tissue in comparison with viable gastric tissue ( p = .03). Fluorescence of the gastrectomy staple line approximated that of viable tissue.
Conclusion
Near‐infrared fluorescence can identify histologically confirmed nonviable gastric tissue. Clinical significance These results provide enough evidence to support the implementation of NIRF as an adjunct to gross examination of the gastric wall in dogs with GDV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA.
- Veterinary Surgicenter, Gainesville, Florida, USA.
- IFAS Statistical Consulting, University of Florida, Gainesville, Florida, USA.
ORCID-Profile: Kaitlyn M Mullen
Förderung
- American College of Veterinary Surgeons Foundation
- Doberman Pinscher Club of America
- Great Dane Club of America
- Poodle Club of America
Zitieren
APA
Mullen, K. M., Regier, P. J., Perez-Rodriguez, V., Fox-Alvarez, W. A., Bertran, J., & Colee, J. (2024). Use of real‐time near‐infrared fluorescence to assess gastric viability in dogs with gastric dilatation volvulus: A case‐control study. Veterinary Surgery. https://doi.org/10.1111/vsu.14067
Vancouver
Mullen KM, Regier PJ, Perez-Rodriguez V, Fox-Alvarez WA, Bertran J, Colee J. Use of real‐time near‐infrared fluorescence to assess gastric viability in dogs with gastric dilatation volvulus: A case‐control study. Veterinary Surgery. 2024. doi:10.1111/vsu.14067
BibTeX
@article{Mullen2024,
author = {Mullen, Kaitlyn M and Regier, Penny J and Perez-Rodriguez, Veronica and Fox-Alvarez, W Alexander and Bertran, Judith and Colee, James},
title = {Use of real‐time near‐infrared fluorescence to assess gastric viability in dogs with gastric dilatation volvulus: A case‐control study},
journal = {Veterinary Surgery},
year = {2024},
doi = {10.1111/vsu.14067}
}
EUVIMED